<DOC>
	<DOCNO>NCT01938430</DOCNO>
	<brief_summary>This study evaluate ledipasvir/sofosbuvir ( LDV/SOF ) fixed-dose combination ( FDC ) plus ribavirin ( RBV ) participant advance liver disease posttransplant chronic genotype 1 4 hepatitis C virus ( HCV ) infection . - Cohort A : decompensated cirrhosis ( advanced liver disease ) , prior liver transplant ; - Cohort B : post-liver transplant , without cirrhosis ; - Group assignment within cohort base severity liver impairment screening ( Child-Pugh-Turcotte ( CPT ) score participant cirrhosis ; fibrosis ; presence disease fibrosing cholestatic hepatitis ( FCH ) group ) - Randomization 1:1 within group 12 24 week LDV/SOF+RBV treatment .</brief_summary>
	<brief_title>Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin Subjects With Chronic HCV With Advanced Liver Disease Post-Liver Transplant</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<criteria>Able provide write informed consent Chronic genotype 1 4 HCV infection Normal ECG Negative serum pregnancy test female subject Male subject female subject childbearing potential must agree use contraception Able comply dose instruction study drug able complete study schedule assessment , include require post treatment visit Serious active medical psychiatric illness HIV hepatitis B viral ( HBV ) infection Stomach disorder could interfere absorption study drug Treated antiHCV medication last 30 day Any prior exposure HCV nonstructural protein ( NS ) 5aspecific inhibitor Use human granulocytemacrophage colonystimulating factor ( GMCSF ) , epoetin alfa therapeutic hematopoietic agent within 2 week screen History clinically significant medical condition associate chronic liver disease Active spontaneous bacterial peritonitis screen Females breastfeed Infection require systemic antibiotic Participated clinical study investigational drug biologic within last 30 day Active history ( last 6 month ) drug alcohol abuse History organ transplant liver kidney</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>